Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

1.

New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.

Lee SFK, Laughon BE, McHugh TD, Lipman M.

Curr Opin Pulm Med. 2019 Mar 6. doi: 10.1097/MCP.0000000000000570. [Epub ahead of print]

PMID:
30865034
2.

Revolutionary new treatment regimens for multidrug-resistant tuberculosis.

McHugh TD, Honeyborne I, Lipman M, Zumla A.

Lancet Infect Dis. 2019 Mar;19(3):233-234. doi: 10.1016/S1473-3099(19)30060-X. No abstract available.

PMID:
30833051
3.

Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.

Story A, Aldridge RW, Smith CM, Garber E, Hall J, Ferenando G, Possas L, Hemming S, Wurie F, Luchenski S, Abubakar I, McHugh TD, White PJ, Watson JM, Lipman M, Garfein R, Hayward AC.

Lancet. 2019 Feb 21. pii: S0140-6736(18)32993-3. doi: 10.1016/S0140-6736(18)32993-3. [Epub ahead of print]

4.

The changing treatment landscape for MDR/XDR-TB - Can current clinical trials revolutionise and inform a brave new world?

Honeyborne I, Lipman M, Zumla A, McHugh TD.

Int J Infect Dis. 2019 Mar;80S:S23-S28. doi: 10.1016/j.ijid.2019.02.006. Epub 2019 Feb 15. No abstract available.

5.

Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study.

Whitworth HS, Badhan A, Boakye AA, Takwoingi Y, Rees-Roberts M, Partlett C, Lambie H, Innes J, Cooke G, Lipman M, Conlon C, Macallan D, Chua F, Post FA, Wiselka M, Woltmann G, Deeks JJ, Kon OM, Lalvani A; Interferon-γ Release Assays for Diagnostic Evaluation of Active Tuberculosis study group.

Lancet Infect Dis. 2019 Feb;19(2):193-202. doi: 10.1016/S1473-3099(18)30613-3. Epub 2019 Jan 14. Erratum in: Lancet Infect Dis. 2019 Feb;19(2):e39. Lancet Infect Dis. 2019 Mar;19(3):e64.

PMID:
30655049
6.

Reducing loss to follow-up during treatment for drug-resistant tuberculosis.

Abubakar I, Lipman M.

Eur Respir J. 2019 Jan 10;53(1). pii: 1802268. doi: 10.1183/13993003.02268-2018. Print 2019 Jan. No abstract available.

PMID:
30630854
7.

HISTOPATHOLOGIC FINDINGS IN FREE-RANGING CALIFORNIA HUMMINGBIRDS, 1996-2017.

Magagna M, Noland E, Tell LA, Purdin G, Rideout B, Lipman MW, Agnew D.

J Wildl Dis. 2018 Nov 26. doi: 10.7589/2018-05-130. [Epub ahead of print]

PMID:
30475658
8.

Discordance in latent tuberculosis (TB) test results in patients with end-stage renal disease.

Southern J, Sridhar S, Tsou CY, Hopkins S, Collier S, Nikolayevskyy V, Lozewicz S, Lalvani A, Abubakar I, Lipman M.

Public Health. 2019 Jan;166:34-39. doi: 10.1016/j.puhe.2018.09.023. Epub 2018 Nov 12.

PMID:
30439554
9.

Psychosocial Distress and Health Service Utilization in Patients Undergoing Hemodialysis: A Prospective Study.

El-Majzoub S, Mucsi I, Li M, Moussaoui G, Lipman ML, Looper KJ, Novak M, Rej S.

Psychosomatics. 2018 Oct 10. pii: S0033-3182(18)30466-3. doi: 10.1016/j.psym.2018.10.001. [Epub ahead of print]

PMID:
30396686
10.

Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.

Abubakar I, Lalvani A, Southern J, Sitch A, Jackson C, Onyimadu O, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Kon OM, Hayward A, Lord J, Drobniewski F.

Health Technol Assess. 2018 Oct;22(56):1-96. doi: 10.3310/hta22560.

11.

Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.

Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Lynn W, Burgess H, Mann B, Imran A, Sridhar S, Tsou CY, Nikolayevskyy V, Rees-Roberts M, Whitworth H, Kon OM, Haldar P, Kunst H, Anderson S, Hayward A, Watson JM, Milburn H, Lalvani A; PREDICT Study Team.

Lancet Infect Dis. 2018 Oct;18(10):1077-1087. doi: 10.1016/S1473-3099(18)30355-4. Epub 2018 Aug 30.

12.

Trends in, and factors associated with, HIV infection amongst tuberculosis patients in the era of anti-retroviral therapy: a retrospective study in England, Wales and Northern Ireland.

Winter JR, Stagg HR, Smith CJ, Lalor MK, Davidson JA, Brown AE, Brown J, Zenner D, Lipman M, Pozniak A, Abubakar I, Delpech V.

BMC Med. 2018 Jun 7;16(1):85. doi: 10.1186/s12916-018-1070-2.

13.

Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.

Aisyah DN, Shallcross L, Hayward A, Aldridge RW, Hemming S, Yates S, Ferenando G, Possas L, Garber E, Watson JM, Geretti AM, McHugh TD, Lipman M, Story A.

J Viral Hepat. 2018 Nov;25(11):1260-1269. doi: 10.1111/jvh.12936. Epub 2018 Jun 20.

PMID:
29851232
14.

Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.

Doyle RM, Burgess C, Williams R, Gorton R, Booth H, Brown J, Bryant JM, Chan J, Creer D, Holdstock J, Kunst H, Lozewicz S, Platt G, Romero EY, Speight G, Tiberi S, Abubakar I, Lipman M, McHugh TD, Breuer J.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00666-18. doi: 10.1128/JCM.00666-18. Print 2018 Aug.

15.

Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort.

Jackson C, Southern J, Lalvani A, Drobniewski F, Griffiths CJ, Lipman M, Bothamley GH, Deeks JJ, Imran A, Kon OM, Mpofu S, Nikolayevskyy V, Rees-Roberts M, Sitch A, Sridhar S, Tsou CY, Whitworth H, Abubakar I.

Thorax. 2019 Jan;74(1):91-94. doi: 10.1136/thoraxjnl-2017-211124. Epub 2018 May 15.

16.

High mortality in patients with Mycobacterium avium complex lung disease: a systematic review.

Diel R, Lipman M, Hoefsloot W.

BMC Infect Dis. 2018 May 3;18(1):206. doi: 10.1186/s12879-018-3113-x.

17.

Radial Head Fracture Fixation Using Tripod Technique With Headless Compression Screws.

Lipman MD, Gause TM, Teran VA, Chhabra AB, Deal DN.

J Hand Surg Am. 2018 Jun;43(6):575.e1-575.e6. doi: 10.1016/j.jhsa.2018.03.009. Epub 2018 Apr 27. Review.

PMID:
29709352
18.

Can somatic GATA2 mutation mimic germ line GATA2 mutation?

Sekhar M, Pocock R, Lowe D, Mitchell C, Marafioti T, Dickinson R, Collin M, Lipman M.

Blood Adv. 2018 Apr 24;2(8):904-908. doi: 10.1182/bloodadvances.2017012617. No abstract available.

19.

The challenge of estimating tuberculosis mortality accurately in England and Wales.

Lalor MK, Mohiyuddin T, Uddin T, Thomas HL, Lipman M, Campbell CNJ.

Int J Tuberc Lung Dis. 2018 May 1;22(5):572-578. doi: 10.5588/ijtld.17.0695.

PMID:
29663964
20.

Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.

Gupta RK, Lipman M, Story A, Hayward A, de Vries G, van Hest R, Erkens C, Rangaka MX, Abubakar I.

Int J Tuberc Lung Dis. 2018 May 1;22(5):479-487. doi: 10.5588/ijtld.17.0767.

PMID:
29663951
21.

Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers.

Mavrakanas TA, Lipman ML.

Can J Diabetes. 2018 Apr;42(2):118-123. doi: 10.1016/j.jcjd.2017.11.006. Epub 2017 Dec 22. Review.

PMID:
29602404
22.

Update in Tuberculosis and Nontuberculous Mycobacteria 2017.

Abubakar I, Gupta RK, Rangaka MX, Lipman M.

Am J Respir Crit Care Med. 2018 May 15;197(10):1248-1253. doi: 10.1164/rccm.201801-0106UP. No abstract available.

PMID:
29537298
23.

Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users.

Oprea C, Ianache I, Calistru PI, Nica M, Ruta S, Smith C, Lipman M.

HIV Med. 2018 May;19(5):316-323. doi: 10.1111/hiv.12576. Epub 2018 Feb 21.

PMID:
29464834
24.

High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population.

Aldridge RW, Hayward AC, Hemming S, Yates SK, Ferenando G, Possas L, Garber E, Watson JM, Geretti AM, McHugh TD, Lipman M, Story A.

Thorax. 2018 Jun;73(6):557-564. doi: 10.1136/thoraxjnl-2016-209579. Epub 2018 Jan 29.

25.

Defective interplay between mTORC1 activity and endoplasmic reticulum stress-unfolded protein response in uremic vascular calcification.

Panda DK, Bai X, Sabbagh Y, Zhang Y, Zaun HC, Karellis A, Koromilas AE, Lipman ML, Karaplis AC.

Am J Physiol Renal Physiol. 2018 Jun 1;314(6):F1046-F1061. doi: 10.1152/ajprenal.00350.2017. Epub 2018 Jan 10.

PMID:
29357413
26.

Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management.

Bahbahani H, AlTurki A, Dawas A, Lipman ML.

BMC Nephrol. 2018 Jan 8;19(1):4. doi: 10.1186/s12882-017-0809-x.

27.

Resilience and Physical and Mental Well-Being in Adults with and Without HIV.

McGowan JA, Brown J, Lampe FC, Lipman M, Smith C, Rodger A.

AIDS Behav. 2018 May;22(5):1688-1698. doi: 10.1007/s10461-017-1980-6.

28.

Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential?

Satta G, Lipman M, Smith GP, Arnold C, Kon OM, McHugh TD.

Clin Microbiol Infect. 2018 Jun;24(6):604-609. doi: 10.1016/j.cmi.2017.10.030. Epub 2017 Nov 3. Review.

29.

Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results.

Brown J, Kumar K, Reading J, Harvey J, Murthy S, Capocci S, Hopkins S, Seneviratne S, Cropley I, Lipman M.

Eur Respir J. 2017 Oct 26;50(4). pii: 1701267. doi: 10.1183/13993003.01267-2017. Print 2017 Oct. No abstract available.

PMID:
29074546
30.

Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis.

Kodama C, Lange B, Olaru ID, Khan P, Lipman M, Seddon JA, Sloan D, Grandjean L, Ferrand RA, Kranzer K.

Eur Respir J. 2017 Oct 26;50(4). pii: 1701044. doi: 10.1183/13993003.01044-2017. Print 2017 Oct. Review. No abstract available.

PMID:
29074544
31.

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis.

Murphy ME, Phillips PPJ, Mendel CM, Bongard E, Bateson ALC, Hunt R, Murthy S, Singh KP, Brown M, Crook AM, Nunn AJ, Meredith SK, Lipman M, McHugh TD, Gillespie SH; REMoxTB Consortium.

BMC Med. 2017 Oct 27;15(1):192. doi: 10.1186/s12916-017-0947-9.

32.

Brief Mindfulness Meditation for Depression and Anxiety Symptoms in Patients Undergoing Hemodialysis: A Pilot Feasibility Study.

Thomas Z, Novak M, Platas SGT, Gautier M, Holgin AP, Fox R, Segal M, Looper KJ, Lipman M, Selchen S, Mucsi I, Herrmann N, Rej S.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2008-2015. doi: 10.2215/CJN.03900417. Epub 2017 Oct 12.

33.

The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.

Mangtani P, Nguipdop-Djomo P, Keogh RH, Sterne JAC, Abubakar I, Smith PG, Fine PEM, Vynnycky E, Watson JM, Elliman D, Lipman M, Rodrigues LC.

Int J Epidemiol. 2018 Feb 1;47(1):193-201. doi: 10.1093/ije/dyx141.

34.

Fibromyalgia as a Predictor of Complex Regional Pain Syndrome After Distal Radius Fracture.

Lipman MD, Hess DE, Werner BC, Deal DN.

Hand (N Y). 2017 Oct 1:1558944717735949. doi: 10.1177/1558944717735949. [Epub ahead of print]

PMID:
29020809
35.

Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV.

Winter JR, Stagg HR, Smith CJ, Brown AE, Lalor MK, Lipman M, Pozniak A, Skingsley A, Kirwan P, Yin Z, Thomas HL, Delpech V, Abubakar I.

AIDS. 2017 Nov 13;31(17):2403-2413. doi: 10.1097/QAD.0000000000001635.

PMID:
28857827
36.

Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.

Zenner D, Beer N, Harris RJ, Lipman MC, Stagg HR, van der Werf MJ.

Ann Intern Med. 2017 Aug 15;167(4):248-255. doi: 10.7326/M17-0609. Epub 2017 Aug 1. Review.

PMID:
28761946
37.

Access to influenza immunisation services by HIV-positive patients in the UK.

Pickett E, Brown J, van Schalkwyk M, Hunter A, Edwards K, Edwards S, Marshall N, Swaden L, Burns F, Johnson M, Lipman M.

Influenza Other Respir Viruses. 2018 Jul;12(4):544-546. doi: 10.1111/irv.12473. Epub 2018 Mar 30. No abstract available.

38.

Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.

Mangtani P, Nguipdop-Djomo P, Keogh RH, Trinder L, Smith PG, Fine PE, Sterne J, Abubakar I, Vynnycky E, Watson J, Elliman D, Lipman M, Rodrigues LC.

Health Technol Assess. 2017 Jul;21(39):1-54. doi: 10.3310/hta21390.

39.

Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.

Arnold A, Cooke GS, Kon OM, Dedicoat M, Lipman M, Loyse A, Chis Ster I, Harrison TS.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e02586-16. doi: 10.1128/AAC.02586-16. Print 2017 Sep.

40.

Tuberculosis treatment outcomes among disadvantaged patients in India.

Jackson C, Stagg HR, Doshi A, Pan D, Sinha A, Batra R, Batra S, Abubakar I, Lipman M.

Public Health Action. 2017 Jun 21;7(2):134-140. doi: 10.5588/pha.16.0107.

41.

An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation.

Pfeffer PE, Hopkins S, Cropley I, Lowe DM, Lipman M.

Respir Res. 2017 May 15;18(1):93. doi: 10.1186/s12931-017-0579-9.

42.

Corrigendum: Headache in an HIV positive patient: diagnostic challenges and approach to treatment.

Creamer A, Ioannidis S, Wilhelm T, Mahungu T, Lipman M.

Clin Med (Lond). 2017 Apr;17(2):153. doi: 10.7861/clinmedicine.17-2-153. No abstract available.

43.

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients.

Mavrakanas TA, Samer CF, Nessim SJ, Frisch G, Lipman ML.

J Am Soc Nephrol. 2017 Jul;28(7):2241-2248. doi: 10.1681/ASN.2016090980. Epub 2017 Mar 16.

44.

Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.

Brown J, McGowan JA, Chouial H, Capocci S, Smith C, Ivens D, Johnson M, Sathia L, Shah R, Lampe FC, Rodger A, Lipman M.

HIV Med. 2017 Sep;18(8):604-612. doi: 10.1111/hiv.12497. Epub 2017 Mar 13.

PMID:
28294498
45.

Isoniazid-resistant tuberculosis: a cause for concern?

Stagg HR, Lipman MC, McHugh TD, Jenkins HE.

Int J Tuberc Lung Dis. 2017 Feb 1;21(2):129-139. doi: 10.5588/ijtld.16.0716. Review.

46.

Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.

Lipman MD, Carstensen SE, Deal DN.

Hand (N Y). 2017 Jan;12(1):13-20. doi: 10.1177/1558944716647101. Epub 2016 May 3. Review.

47.

Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014.

Arnold A, Cooke GS, Kon OM, Dedicoat M, Lipman M, Loyse A, Butcher PD, Ster IC, Harrison TS.

J Infect. 2017 Mar;74(3):260-271. doi: 10.1016/j.jinf.2016.12.005. Epub 2016 Dec 18.

48.

Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis.

Brown J, Roy A, Harris R, Filson S, Johnson M, Abubakar I, Lipman M.

Thorax. 2017 Apr;72(4):355-366. doi: 10.1136/thoraxjnl-2016-208657. Epub 2016 Oct 24. Review.

49.
50.

Occupational Tuberculosis despite Minimal Nosocomial Contact in a Health Care Worker Undergoing Treatment with a Tumor Necrosis Factor Inhibitor.

Murphy ME, Wilmore S, Satta G, Witney A, Atzeni A, Sturgeon K, Cropley I, McHugh TD, Hopkins S, Lipman M.

Ann Am Thorac Soc. 2016 Dec;13(12):2275-2277. No abstract available.

PMID:
27925777

Supplemental Content

Loading ...
Support Center